共 50 条
CAR-T Cells Targeting Immune Checkpoint Pathway Players
被引:10
|作者:
Golubovskaya, Vita
[1
]
机构:
[1] Promab Biotechnol, Richmond, CA 94806 USA
来源:
关键词:
CAR-T cell;
tumor;
checkpoint;
immunotherapy;
review;
CHIMERIC ANTIGEN RECEPTORS;
ACUTE MYELOID-LEUKEMIA;
TUMOR-CELLS;
ANTITUMOR-ACTIVITY;
OVARIAN-CANCER;
STEM-CELLS;
B7;
FAMILY;
ANTIBODY;
IMMUNOTHERAPY;
EXPRESSION;
D O I:
10.31083/j.fbl2704121
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
CAR (Chimeric antigen receptor)-T cell therapy has become a very promising type of immunotherapy against hematological cancers. This report is focused on CAR-T cells targeting immune checkpoint proteins expressed on tumor cells. The CD70, CD47, CD80, CD86, B7H3, B7H4, PDL-1, TIGIT CAR-T cells and other CAR-T cells are discussed as an effective approach to deplete tumor cells expressing checkpoint proteins. CAR-T cell therapy targeting checkpoint pathways is a promising therapy to decrease inhibitory signaling pathways. The review highlights future directions and perspectives in CAR-T cells targeting immune checkpoint pathways.
引用
收藏
页数:11
相关论文